|
CDR1
|
PDR1
|
ERG4
|
---|
Strain |
RDN5.8
|
ACT1
|
RDN5.8
|
ACT1
|
RDN5.8
|
ACT1
|
---|
NCCLS84
| 2.12* | 0.19* | 2.22* | 0.20* | 2.85* | 0.26* |
Cg84u
| 3.90* | 0.42* | 3.26* | 0.50* | 10.04* | 0.68* |
CgB4
| 0.64# | 0.06* | 1.08# | 0.10* | 2.42* | 0.22* |
Cg3S
| 2.59* | 0.23* | 3.31* | 0.30* | 3.84* | 0.35* |
Cg4R
| 2.14* | 0.19* | 3.68* | 0.33* | 5.34* | 0.48* |
- ¶Values indicate the fold change in RNA transcription for each target gene in fluconazole-treated C. glabrata, as compared with untreated cells.
- ΔCT = CTtarget − CTreference; ΔCT of each target gene was calculated by using RDN5.8 or ACT1 as the reference.
- ΔΔCT(t) = ΔCT(t) − ΔCT(ut); ut, untreated; t, fluconazole-treated. Fold change = 2-ΔΔCT(t).
- Fold changes of the target genes were also computed with the hkgFinder tool by using RDN5.8 or ACT1 as the reference.
- #P > 0.05 and *P <; 0.05 for the azole-treated group vs. the untreated group after normalization to RDN5.8 or ACT1.